Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Oxybutynin Hydrochloride
DRUG
2 trials
Sponsors
Astellas Pharma Inc
, Central Hospital, Nancy, France
Conditions
Multiple Sclerosis
Neurogenic Bladder
Spina Bifida
Spinal Cord Diseases
Phase 3
Efficacy of Intravesical Oxybutynin in Children With Neurogenic Bladder Dysfunction
Recruiting
NCT07027020
Central Hospital, Nancy, France
Spina Bifida
Start: 2026-01-15
End: 2028-06-01
Target: 60
Updated: 2026-04-14
Phase 4
Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis
Completed
NCT00629642
Astellas Pharma Inc
Multiple Sclerosis, Neurogenic Bladder, Spinal Cord Diseases
Start: 2008-03-14
End: 2011-01-28
Updated: 2024-11-14
Related Papers
Intravesical oxybutynin for bladder capacity in children with spina bifida: the 'Place de l'OXybutynine Intravésicale chez le Patient Enfant Neurologique' (POXIPEN) trial protocol.
2025-11-03